Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

It kills about half a million people every year. Pancreatic cancer can often be halted, but it's rarely detected in time. The ...

US FDA clears expanded use of Alcresta Therapeutics’ RELiZORB cartridge for paediatric patients 1 year of age and older: Waltham, Massachusetts Friday, January 17, 2025, 17:00 H ...